People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
The National Institute for Health and Clinical Excellence (NICE) has published the first in a new series of guidances for people involved in handling, prescribing, commissioning and decision-making ...
The National Institute for Health and Clinical Excellence (NICE) is to produce a best-practice guide to help NHS trusts and clinical commissioning groups (CCGs) develop local formularies. The National ...
Oral phosphodiesterase type 5 (PDE5) inhibitors are the recommended first-line option for the treatment of erectile dysfunction. Currently, three PDE5 inhibitors are approved for use in the United ...
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results